1. Chronological alterations in de novo malignancies after living-donor liver transplantation: A cohort study of 1781 recipients using annual comparisons of standardized incidence ratios.
- Author
-
Tajima T, Hata K, Tanaka K, Iyama N, Kusakabe J, Kageyama S, Ogawa E, Okamoto T, Haga H, Uemoto S, and Hatano E
- Subjects
- Humans, Male, Female, Middle Aged, Incidence, Retrospective Studies, Japan epidemiology, Adult, Neoplasms epidemiology, Postoperative Complications epidemiology, Aged, Time Factors, Young Adult, Liver Transplantation, Living Donors
- Abstract
Background: De novo malignancies (DNMs) are a major adverse event after solid organ transplantation; however, their characteristics and recent trends after living-donor liver transplantation (LDLT) remain unclear., Methods: We retrospectively reviewed 1781 primary LDLT recipients (1990-2020) and annually calculated standardized incidence ratios (SIRs) of DNMs compared to the age-adjusted Japanese general population., Results: After 21 845 person-years follow-up, 153 DNM lesions (8.6%) were identified in 131 patients (7.4%). The incidence was 0.007 person-years. DNMs included 81 post-transplant lymphoproliferative disorders (PTLDs), 14 colorectal, 12 lung, and 12 gastric cancers, and so on. Comorbid DNMs significantly worsened recipient survival than those without (p < .001). The 5- and 10-year recipient survival after DNM diagnosis were 65% and 58%, respectively. Notably, SIR
1993-1995 : 8.12 (95% CI: 3.71-15.4, p < .001) and SIR1996-1998 : 3.11 (1.34-6.12, p = .01) were significantly high, but had decreased time-dependently to SIR2005-2007 : 1.31 (0.68-2.29, p = .42) and SIR2008-2010 : 1.34 (0.75-2.20, p = .33), indicating no longer significant difference in DNMs development. Currently, however, SIR2014-2016 : 2.27 (1.54-3.22, p < .001) and SIR2017-2019 : 2.07 (1.40-2.96, p < .001) have become significantly higher again, reflecting recent aging of recipients (>50 years) and resultant increases in non-PTLD DNMs. Furthermore, characteristically in LDLT, the fewer the donor-recipient HLA-mismatches, the less the post-transplant DNMs development., Conclusion: DNM development after LDLT was significantly higher than in the general population due to higher PTLD incidence (1993-1998), but once became equivalent (2005-2013), then significantly increased again (2014-2019) due to recent recipient aging and resultant increase in solid cancers., (© 2024 The Author(s). Journal of Hepato‐Biliary‐Pancreatic Sciences published by John Wiley & Sons Australia, Ltd on behalf of Japanese Society of Hepato‐Biliary‐Pancreatic Surgery.)- Published
- 2024
- Full Text
- View/download PDF